BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7880654)

  • 1. Ovarian hyperstimulation syndrome.
    Williamson K; Mushambi MC
    Br J Anaesth; 1994 Dec; 73(6):731-3. PubMed ID: 7880654
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent ovarian hyperstimulation syndrome with perforated appendicitis following induction ovulation with HMG and HCG.
    Bouzari Z; Yazdani S; Sadeghi T
    Am J Emerg Med; 2016 Oct; 34(10):2051.e5-2051.e6. PubMed ID: 27066875
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention and treatment of ovarian hyperstimulation.
    Schenker JG
    Hum Reprod; 1993 May; 8(5):653-9. PubMed ID: 8314955
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian hyperstimulation syndromes].
    Antoine JM; Salat-Baroux J
    Contracept Fertil Sex; 1993 Mar; 21(3):201-7. PubMed ID: 7951613
    [No Abstract]   [Full Text] [Related]  

  • 6. High renin and prorenin in plasma and pleural exudate of a patient with the ovarian hyperstimulation syndrome.
    van de Vrie W; Baggen MG; Visser W; Derkx FH; Morrel B; Ouwendijk RJ
    Neth J Med; 1997 Dec; 51(6):232-6. PubMed ID: 9499695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated pleural effusion in severe ovarian hyperstimulation: A case report.
    Gregory WT; Patton PE
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1468-71. PubMed ID: 10368491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correct timing of administration of diuretic agents for the treatment of ovarian hyperstimulation syndrome.
    Bar-Hava I; Homburg R
    Gynecol Endocrinol; 1993 Mar; 7(1):63-5. PubMed ID: 8506765
    [No Abstract]   [Full Text] [Related]  

  • 9. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
    Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
    Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe complications of ovarian hyperstimulation syndrome are preventable.
    Murdoch AP; Evbuomwan I
    Hum Reprod; 1999 Nov; 14(11):2922-3. PubMed ID: 10548650
    [No Abstract]   [Full Text] [Related]  

  • 13. Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome.
    Vavilis D; Tzitzimikas S; Agorastos T; Loufopoulos A; Tsalikis T; Bontis JN
    Fertil Steril; 2002 Apr; 77(4):841-3. PubMed ID: 11937145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of ovarian hyperstimulation syndrome: novel strategies.
    Grudzinskas JG; Egbase PE
    Hum Reprod; 1998 Aug; 13(8):2051-3. PubMed ID: 9756266
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and management of ovarian hyperstimulation syndrome.
    Nelson SM
    Thromb Res; 2017 Mar; 151 Suppl 1():S61-S64. PubMed ID: 28262238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian hyperstimulation syndrome.
    McElhinney B; McClure N
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Feb; 14(1):103-22. PubMed ID: 10789263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long hospitalization for severe ovarian hyperstimulation syndrome with persistent right hydrothorax and two occurrences of pneumonia.
    Lin J; Li X; Zhang L
    Int J Gynaecol Obstet; 2017 Mar; 136(3):350-352. PubMed ID: 28099716
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
    van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
    Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrĂ©vention du syndrome d'hyperstimulation ovarienne.
    Corbett S; Shmorgun D; Claman P
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S512-S524. PubMed ID: 28063561
    [No Abstract]   [Full Text] [Related]  

  • 20. Upper limb thrombosis associated with assisted conception treatment.
    Stewart JA; Hamilton PJ; Murdoch AP
    Hum Reprod; 1997 Oct; 12(10):2174-5. PubMed ID: 9402277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.